Skip to content
Recall Observatory FDA recall evidence

Drug product

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)

D-0003-2023

September 27, 2022

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 90903
Status
Terminated
Classification
Class II
Quantity
103,150 10 mL vials
Official record key
drug-enforcement:D-0003-2023

Official wording

Reason: Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.

Code information: Lot: 30-137-DK Exp. 1 DEC. 2022

Distribution pattern: Distributed in the United States and Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter